Lobbying

Association for Diagnostics & Laboratory Medicine's latest lobbying report covers Q2 2026, at $120K. The four quarters Q3 2025–Q2 2026 total $320K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Medical/Disease Research/Clinical Labs.

Association for Diagnostics & Laboratory Medicine

Latest quarter
$120K
Q2 2026 · 1 reports
Last 12 months
$320K
Last 4 quarters
vs last quarter
0.0%
Q2 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Association for Diagnostics & Laboratory Medicine lobbying by quarter
Association for Diagnostics & Laboratory Medicine lobbying by quarter
QuarterAmountReports
Q4 2022$160K1
Q1 2023$70K1
Q2 2023$170K1
Q3 2023$70K1
Q4 2023$160K1
Q1 2024$50K1
Q2 2024$140K1
Q3 2024$60K1
Q4 2024$60K1
Q1 2025$130K1
Q2 2025$150K1
Q3 2025$40K1
Q4 2025$40K1
Q1 2026$120K1
Q2 2026$120K1

Policy issues the reports name

  • Budget and appropriations15 reports
  • Medical research and clinical labs12 reports
  • Health issues5 reports
  • Medicare and Medicaid3 reports
  • Government issues1 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Health & Human Services, Dept of (HHS)5 reports
  • Centers For Disease Control & Prevention (CDC)2 reports
  • Office of Management & Budget (OMB)2 reports
  • Centers For Medicare and Medicaid Services (CMS)1 reports
  • Food & Drug Administration (FDA)1 reports
  • Homeland Security, Dept of (DHS)1 reports
  • Natl Institutes of Health (NIH)1 reports

Firms it paid

Firm
In-houseAssociation for Diagnostics & Laboratory Medicine$1.5M15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/16for Q2In-house$120K
04/15for Q1In-house$120K
01/09for Q4 2025In-house$40K
25/10/27for Q3 2025In-house$40K
25/07/11for Q2 2025In-house$150K
25/04/16for Q1 2025In-house$130K
25/01/08for Q4 2024In-house$60K
24/10/16for Q3 2024In-house$60K
24/08/15for Q2 2024In-house$140K
24/04/10In-houseUnder $5,000
24/04/10for Q1 2024In-house$50K
24/01/18for Q4 2023In-house$160K
23/10/16for Q3 2023In-house$70K
23/07/14for Q2 2023In-house$170K
23/04/11for Q1 2023In-house$70K
23/01/06for Q4 2022In-house$160K